Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
8.25M
-
Shares change
-
-981K
-
Total reported value, excl. options
-
$124M
-
Value change
-
-$16.8M
-
Number of buys
-
30
-
Number of sells
-
-27
-
Price
-
$14.99
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2021
64 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q2 2021.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.25M shares
of 22M outstanding shares and own 37.43% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (1.69M shares), RTW INVESTMENTS, LP (821K shares), COWEN AND COMPANY, LLC (726K shares), BlackRock Inc. (586K shares), VANGUARD GROUP INC (520K shares), PLATINUM INVESTMENT MANAGEMENT LTD (400K shares), Nantahala Capital Management, LLC (368K shares), NOMURA HOLDINGS INC (355K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (310K shares), and DEUTSCHE BANK AG\ (306K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.